Clinical trials

  • PF-07328948 for Heart failure
  • (2R,3R,11BR)-1,3,4,6,7,11B-HEXAHYDRO-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-2H-BENZO[A]QUINOLIZIN-2-OL for Tardive dyskinesia
  • ZINC ACEXAMATE for Advanced chronic liver disease | Chronic liver disease
  • Argipressin (arginine vasopressin) for Vasoplegic shock (norepinephrine-refractory)
  • CEFEPIME HYDROCHLORIDE for Sepsis | Hospital-acquired sepsis
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Piriformis muscle syndrome|Piriformis syndrome
  • RUCAPARIB for Ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • Midazolam for Breech (podalic) or transverse fetal presentation (dystocic fetal presentation)
  • Pembrolizumab for Recurrent platinum-resistant ovarian cancer | Recurrent platinum-resistant fallopian tube cancer | Recurrent platinum-resistant primary peritoneal cancer
  • CLADRIBINE for Myasthenia gravis|Seropositive myasthenia gravis
  • trastuzumab deruxtecan for Advanced solid tumor
  • OLAPARIB for ER-positive, HER2-negative breast cancer | Metastatic breast cancer | Locally advanced breast cancer